Adjust Text Size:change font sizechange font sizechange font sizechange font sizechange font sizechange font size

Light of Day Foundation Challenge

Light of Day Challenge

Goal: $100,000

Raised: $72,597


Donate Now


Educational Materials


Do you want to know more about Parkinson's? PDF's materials provide information about symptoms, medications, resources & more.

Order Free Materials Today

Parkinson's HelpLine


Whatís in the PD Pipeline?

Hosted by PDF and the Parkinson Association of the Carolinas
Charlotte, NC 
Friday, May 9, 2008

“What’s in the PD Pipeline?” is an educational webcast for people with PD, caregivers and family members and health professionals.  The live program was presented Friday, May 9, in Charlotte NC, where three leading Parkinson's scientistists discussed the role of genetics in Parkinson's disease and the newest potential treatments under investigation, such as gene therapy and stem cells.


9:00 AM -  Registration

10:00 AM- Genetic Lessons and New Approaches in Learning about Parkinson’s Diseases
                   Katrina Gwinn, M.D., National Institutes of Health/National Institute of Neurological Disorders and Stroke

10:50 AM - Break

11:10 AM - Recent and Future Innovation in the Treatment of Parkinson’s Disease
                    Mark Stacy, M.D., Duke University Medical Center

12:00 PM - LUNCH

1:15 PM -   Stem Cells and Gene Therapy for Parkinson’s Disease: Is the Cure on the Horizon?
                   Clive Svendsen, Ph.D., University of Wisconsin-Madison

2: 05 PM -   Break

2:20 PM -   Open Questions

Speaker Biographies

Katrina Gwinn, M.D.

Katrina Gwinn, M.D., is a Program Director of the Extramural Research Program at the National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS). She was formerly a faculty member at the Mayo Clinic in Scottsdale, Arizona, where she worked until coming to the NIH in 2001.

Dr. Gwinn has published close to 100 peer reviewed scientific papers, primarily on the subject of genetics and Parkinson’s disease (PD). She was named one of the “Best Doctors in America” in 2001 and 2005, was awarded the NIH Director’s Award for her work in Neurogenetics and has been inducted into the American Neurological Association.

Dr. Gwinn received her undergraduate degree from Wellesley College . She received her M.D. degree from Vanderbilt University, completed a Neurology residency at University of Michigan , and performed a fellowship in Parkinson’s Disease and other Movement Disorders at the Mayo Clinic in Scottsdale.

On a personal note, her father has Parkinson’s disease and provides a great deal of inspiration and insight into her work.

Mark Stacy, M.D.

Mark Stacy, M.D., is an Associate Professor of Neurology and Director of the Movement Disorders Program at Duke University.

He has clinical trial experience in Parkinson’s disease, Dystonia, and Tremor and has served on a number of protocol steering committees and Drug Safety Monitoring Boards. His independent research interests include motor and non-motor symptoms of wearing off, pathological gambling and other impulse control disorders in Parkinson’s.

Dr. Stacy is a member of the American Academy of Neurology, sits on the Board of Directors of WE MOVE, a not-for-profit organization dedicated to education in movement disorders, and is a member of the Parkinson Study Group. He has been named one of the “Best Doctors in America”.

Dr. Stacy completed his medical education at the University of Missouri in 1986. He performed his Neurology residency at Hahnemann University and a Movement Disorders Fellowship at Baylor College of Medicine.

Clive N. Svendsen, Ph.D.

Clive N. Svendsen, Ph.D. is currently Professor of Neurology and Anatomy at the University of Wisconsin-Madison, Director of the National Institutes of Health funded Stem Cell Training Program and Co-Director of the Wisconsin Stem Cell and Regenerative Medicine Program.

His interests center on novel methods of growth factor delivery to the brain using genetically modified human neural stem cells, modeling neurological diseases by over expressing pathogenic genes in human embryonic and fetal stem cells and developing translational stem cell and gene therapies to treat diseases such as Parkinson’s, Huntington’s and amyotrophic lateral sclerosis (ALS or Motor Neuron Disease).

Dr. Svendsen received his Ph.D. from the University of Cambridge.

The content and management of this symposium and webcast are under the exclusive direction of the Parkinson’s Disease Foundation and the Parkinson Association of the Carolinas and are made possible by a generous unrestricted grant from UCB, Inc.